Consistently, analysis of TCGA data for pancreatic cancer patients using GEPIA and Oncomine showed that the cFLIP level is highly elevated in PDAC tumors relative to normal tissues (Fig. 3b, c), indicating that the increased cFLIP level may be involved in TRAIL resistance in PDAC cells. The gene discussed is CFLAR; the disease is pancreatic neoplasm.